Nabriva Therapeutics

+$0.0037 (+1.94%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NBRV and other ETFs, options, and stocks.

About NBRV

Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, CONTEPO, and BC-7013.

CEO
Theodore R. Schroeder
Employees
73
Headquarters
Dublin, Dublin
Founded
2005

NBRV Key Statistics

Market cap
12.35M
Price-Earnings ratio
—
Dividend yield
—
Average volume
601.22K
High today
$0.20
Low today
$0.1856
Open price
$0.198
Volume
378.41K
52 Week high
$2.32
52 Week low
$0.1803

NBRV Earnings

-$1.11
-$0.74
-$0.37
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure